Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02090920 · ClinicalTrials.gov registry record
Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor
A clinical trial of Preterm Labor, sponsored by Indiana University.
- Completed
- Registry status
- 20
- Enrollment target
- 2
- Study locations
NCT02090920: Completed study of Preterm Labor, sponsored by Indiana University.
NCT02090920 is a study of Preterm Labor that has completed, run by Indiana University. The registered enrollment target is 20 participants, below the 6,080-participant average among 8 other Preterm Labor trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02090920, a study of Preterm Labor, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study looks at the effects of a mother's genes and other characteristics (mother's age, baby's age, race, and other diseases) on the ability of nifedipine to end contractions and prevent an early delivery. This information will be used to decide what amount of nifedipine women need to best treat preterm contractions.
Primary Outcome
The primary study outcome is prevention of delivery for 48 hours with attainment of uterine quiescence, defined by 12 hours of six or fewer contractions per hour and no further cervical change. Failure of the primary outcome occurs if, in the first 48 hours, patients deliver, rupture membranes, experience recurrent preterm labor, continue to contract or experience cervical change, or required the use of alternate tocolytics. Secondary outcomes include time to uterine quiescence (≤6 contractions/
Conditions Studied
Interventions
- DRUG Nifedipine
Study Locations (2)
Indiana
- Eskenazi Health - Indianapolis
- IU Health Methodist - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-07 |
| Est. Completion | 2019-04 |
What the finished NCT02090920 record still lists
NCT02090920 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 6,080-participant average among 8 other Preterm Labor trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Preterm Labor appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine is the first listed.
NCT02090920 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT02090920 about?
NCT02090920 is a clinical study titled "Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor". This study looks at the effects of a mother's genes and other characteristics (mother's age, baby's age, race, and other diseases) on the ability of nifedipine to end contractions and prevent an early delivery. This information will be used to decide what amount of nifedipine women need to best trea...
What is the current status of trial NCT02090920?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2019-04.
What conditions does trial NCT02090920 study?
This clinical trial studies the following conditions: Preterm Labor.
What interventions are being tested in trial NCT02090920?
The interventions under investigation include: Nifedipine (DRUG).
Who is sponsoring clinical trial NCT02090920?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02090920 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Labor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02090920's enrollment target sits among peer trials
20 9th of 8 the lowest of 8 other Preterm Labor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Labor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
-
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
RECRUITING · Phase 4
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
ACTIVE NOT RECRUITING · NA
-
MIRACLE of LIFE Study
ACTIVE NOT RECRUITING
-
Omega-3 Fatty Acids for Smoking Cessation in Pregnancy
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia